- Home
- BWEN vs ANVS Comparison
BWEN vs ANVS Comparison
Compare BWEN & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- ANVS
- Stock Information
- Founded
- BWEN N/A
- ANVS 2008
- Country
- BWEN United States
- ANVS United States
- Employees
- BWEN N/A
- ANVS N/A
- Industry
- BWEN Industrial Machinery/Components
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- ANVS Health Care
- Exchange
- BWEN Nasdaq
- ANVS Nasdaq
- Market Cap
- BWEN 49.1M
- ANVS 46.1M
- IPO Year
- BWEN N/A
- ANVS 2020
- Fundamental
- Price
- BWEN $2.21
- ANVS $2.08
- Analyst Decision
- BWEN Strong Buy
- ANVS Strong Buy
- Analyst Count
- BWEN 1
- ANVS 4
- Target Price
- BWEN $6.00
- ANVS $17.33
- AVG Volume (30 Days)
- BWEN 302.3K
- ANVS 1.4M
- Earning Date
- BWEN 11-12-2025
- ANVS 11-12-2025
- Dividend Yield
- BWEN N/A
- ANVS N/A
- EPS Growth
- BWEN N/A
- ANVS N/A
- EPS
- BWEN N/A
- ANVS N/A
- Revenue
- BWEN $145,141,000.00
- ANVS N/A
- Revenue This Year
- BWEN $8.75
- ANVS N/A
- Revenue Next Year
- BWEN $3.50
- ANVS N/A
- P/E Ratio
- BWEN N/A
- ANVS N/A
- Revenue Growth
- BWEN N/A
- ANVS N/A
- 52 Week Low
- BWEN $1.41
- ANVS $1.11
- 52 Week High
- BWEN $3.03
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- BWEN 47.88
- ANVS 49.13
- Support Level
- BWEN $2.17
- ANVS $1.97
- Resistance Level
- BWEN $2.46
- ANVS $2.24
- Average True Range (ATR)
- BWEN 0.19
- ANVS 0.16
- MACD
- BWEN -0.01
- ANVS 0.03
- Stochastic Oscillator
- BWEN 18.18
- ANVS 76.15
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.